Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
April 3, 2020

Novartis unveils plans to begin trial with Jakavi in severe COVID-19 patients

Novartis has unveiled plans to commence a clinical trial of Jakavi (ruxolitinib) in severe COVID-19 patients and establish an international compassionate use programme.

Continue
Novartis has unveiled plans to start trial with Jakavi in severe COVID-19 patients. (Credit: PIRO4D from Pixabay.)
April 2, 2020

Citius, Novellus collaborate on novel stem-cell therapy for ARDS associated with COVID-19

Citius and Novellus have collaborated on novel stem-cell therapy for acute respiratory distress syndrome associated with COVID-19. (Credit: dianakuehn30010 from Pixabay)
April 1, 2020

Tsinghua and partners to develop neutralising antibodies against COVID-19

Tsinghua University, 3rd People’s Hospital of Shenzhen and Brii Bio join forces to develop neutralising antibodies against COVID-19. (Credit: Pete Linforth from Pixabay)

Contracts

April 2, 2020

Concert Pharmaceuticals announces plans for CTP-543 phase 3 trials in alopecia areata

Alopecia areata is an autoimmune disorder that results in patchy or complete hair loss (Credit: kalhh from Pixabay.)

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

Deals

Deals March 9, 2020

AbbVie receives marketing authorisation from EC to shorten MAVIRET duration for treatment-naïve genotype 3 HCV patients with compensated cirrhosis

Pharmaceutical Business Review

Gilead Sciences to buy immuno-oncology firm Forty Seven for $4.9bn

Japan’s Takeda buys PvP Biologics in $330m deal

AstraZeneca divests global rights to Movantik

Popular

  1. Gilead, Renown Institute for Health Innovation announce collaboration to advance understanding of NASH
  2. Celsius Therapeutics signs collaboration agreement with Janssen to identify response biomarkers for ulcerative colitis
  3. Ipsen, Servier announce initial phase 1/2 data of liposomal irinotecan in metastatic pancreatic cancer
  4. VALBIOTIS announces positive results from phase IIA trial of VALEDIA in prediabetics
  5. GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis

PRESS RELEASES

Tosoh Bioscience Introduces SkillPak™ Pre-packed Columns
Tosoh Bioscience Introduces SkillPak™ Pre-packed Columns
Nubilaria against Covid-19
Nubilaria against Covid-19
Enamine to be Exclusive Supplier of Astex’ Mini Frag Library
Enamine to be Exclusive Supplier of Astex’ Mini Frag Library
Pharmaceutical Business Review
Upcoming webinar: Clinical Investigations – Transitioning From MDD to MDR
Packaging Innovations Provides Ideal Platform for Labelling Solutions
Packaging Innovations Provides Ideal Platform for Labelling Solutions

Suppliers

Whitepapers

Morpholine Bioisosteres for Drug Design
Morpholine Bioisosteres for Drug Design
P(O)Me2-containing Building Blocks for Drug Design
P(O)Me2-containing Building Blocks for Drug Design
Optimize your Clinical Trial Supply Chain Management with Advanced Analytics
Optimize your Clinical Trial Supply Chain Management with Advanced Analytics